Navigation Links
Dialysis Corporation of America Announces First Quarter 2008 Earnings Release Date

LINTHICUM, Md., April 25 /PRNewswire-FirstCall/ -- Dialysis Corporation of America (Nasdaq: DCAI) announced today that it will release its first quarter 2008 financial results on May 7, 2008, after the close of the market. The company will also host a conference call in conjunction with its first quarter 2008 earnings release the following morning, May 8, 2008 at 10:00 AM EDT.

Those interested in participating in the May 8, 2008 conference call may dial in at 1-800-260-6066 using pass code 7002477, or through simulcast on the internet at . Participants may be asked to provide the title of the conference call, which is "Dialysis Corporation of America 1st Quarter Earnings." The conference call will be available for replay on the company's website for a period of thirty days following the call.

Dialysis Corporation of America currently owns 35 free standing kidney hemodialysis centers in Pennsylvania, New Jersey, Georgia, Ohio, Maryland, Virginia and South Carolina providing patients with a full range of quality in-center and at-home hemodialysis services, as well as providing in-hospital services in many of the company's markets.

This release contains forward-looking statements that are subject to risks and uncertainties that could cause actual results and plans to differ materially from those anticipated. Those factors include, but are not limited to delays beyond the company's control with respect to future business events, regulation of dialysis operations, determination of reimbursement rates by Medicare and private payers, and other risks detailed in the company's filings with the SEC, particularly as described in the company's annual report on Form 10-K for the fiscal year ended December 31, 2007.

The company's press releases, corporate profile, corporate governance materials, quarterly and current reports, and other filings with the SEC are available on Dialysis Corporation of America's internet home page: .

SOURCE Dialysis Corporation of America
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Angiotech showcases its Hemostream(TM) Dialysis Catheter at the Society of Interventional Radiology (SIR) Annual Meeting
2. Genzyme Launches Renvela(R) in the U.S. for Dialysis Patients
3. FDA Approves Genzymes Renvela(TM) for Dialysis Patients
4. Hemo-Stream(TM) Chronic Dialysis Catheter Receives FDA Clearance
5. Environmental Tectonics Corporations BioMedical Division Announces Sale of Two Hyperbaric Chambers
6. LifeCell Corporation Schedules First Quarter 2008 Financial Results Conference Call; April 24, 2008 at 10:00 A.M. Eastern
7. eBioscience Corporation Announced Today That James Glynn Has Been Appointed to Its Board of Directors, Effective April 15, 2008
8. Sumitomo Corporation of America Named Exclusive Distribution and Sales Agent for Chiral Quest
9. IBF Conferences Inc*International Business Forum and BioEnterprise Corporation present the 2nd Annual Global Healthcare Investing Conference
10. Sigma-Aldrich Corporation 1st Quarter 2008 Earnings Conference Call
11. Kensey Nash Corporation Announces Its Third Quarter 2008 Earnings Release Date and Teleconference
Post Your Comments:
(Date:11/24/2015)... Malaysia , Nov. 24, 2015  Asia-Pacific ... contract research organisation (CRO) market. The trend of ... in lower margins but higher volume share for ... capacity and scale, however, margins in the CRO ... Organisation (CRO) Market ( ), finds ...
(Date:11/24/2015)... , ... November 24, 2015 , ... ... healthy metabolism. But unless it is bound to proteins, copper is also toxic ... (NIH), researchers at Worcester Polytechnic Institute (WPI) will conduct a systematic study of ...
(Date:11/24/2015)... (PRWEB) , ... November 24, 2015 , ... This fall, ... at competitive events in five states to develop and pitch their BIG ideas to ... from each state are competing for votes to win the title of SAP's Teen ...
(Date:11/24/2015)... Nov. 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... that the remaining 11,000 post-share consolidation (or 1,100,000 ... (the "Series B Warrants") subject to the previously ... November 23, 2015, which will result in the ... effect to the issuance of such shares, there ...
Breaking Biology Technology:
(Date:11/17/2015)... , November 17, 2015 ... au 19 novembre  2015.  --> Paris ... --> DERMALOG, le leader de l,innovation biométrique, ... la fois passeports et empreintes sur la même surface ... les passeports et l,autre pour les empreintes digitales. Désormais, ...
(Date:11/12/2015)... 2015  Arxspan has entered into an agreement ... for use of its ArxLab cloud-based suite of ... partnership will support the institute,s efforts to electronically ... information internally and with external collaborators. The ArxLab ... the Institute,s electronic laboratory notebook, compound and assay ...
(Date:11/9/2015)... DUBLIN , Nov. 09, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Law Enforcement Biometrics Market 2015-2019" ... Research and Markets ( ) ...
Breaking Biology News(10 mins):